New Zealand vs South-East Asia (WHO region): New cases tested for RR-/MDR-TB
New Zealand
100.0%
in 2014
South-East Asia (WHO region)
91.0%
in 2024
New Zealand rank
1st
South-East Asia (WHO region) rank
1st
New cases tested for RR-/MDR-TB over time
- New Zealand
- South-East Asia (WHO region)
How they compare
New Zealand currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes New Zealand's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 10 years both countries report, New Zealand has been ahead every year.
New Zealand ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 0.1% | 99.9% | New Zealand |
| 2010s | 80.5% | 1.2% | 79.2% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, New Zealand or South-East Asia (WHO region)?
- New Zealand, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2014.
- What is the difference in new cases tested for rr-/mdr-tb between New Zealand and South-East Asia (WHO region)?
- 9.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and South-East Asia (WHO region)?
- 10 years are reported by both, from 2005 to 2014.
- How do New Zealand and South-East Asia (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- New Zealand ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.